UF Innovate | Sid Martin Biotech is a world-recognized leader in biotechnology business incubation – and with well-equipped laboratories and specialized equipment, plus an outstanding network of mentors, advisors and collaborators, it’s the perfect place for you to grow your biotech business.
We are here to assist you in growing your therapeutic, diagnostics, medical device, ag-bio, clean energy and/or biopharma enterprise. We’ve been making growth happen in North Central Florida since 1995, and we know what it takes to assist your company.
Mark is the director of incubation services at UF. This includes UF Innovate | Sid Martin Biotech and UF Innovate | The Hub. He focuses on incubating companies according to industry best practices efforts, utilizing sales and marketing techniques and entrepreneurial mentoring.
Mark was the former President and CEO of the Indiana University Research and Technology Corporation (IURTC), which owned and operated the Indiana University Emerging Technologies Center (IUETC), a life sciences incubator, and Mark served as President and CEO of that facility. Mark was also President and CEO of the Midwest Proton Radiotherapy Institute, a cancer treatment facility located at Indiana University, during his tenure at IURTC. Mark was the former Director of Technical Operations at Washington University in St. Louis.
Mark has a B.S. in biology and an M.S. in Molecular Biology from Florida State University. He attended both Florida Atlantic University and Indiana University for work on his Ed.D. He has been a member of the NBIA for 12 years and authored the books “Put It In Writing 2”, “Wholesale Economic Development”, and writes a blog on incubation titled IncubatorBlogger.
Merrie focuses on the life science incubator, Sid Martin Biotech, where she manages the day to day operations as well as promotes Incubation Services and recruits companies. Merrie oversees finance, budgets, administration and human resources. Merrie has attended numerous management classes at the International Business Innovation Association (InBIA) conferences and training sessions, and she helped the Sid Martin incubation program win global incubator of the year awards twice, in 2013 and again in 2017.
Merrie has been with UF for 13 years. Previously, she was an orthopedic surgical assistant in south Florida for 15 years, and then she assisted various hospital
foundations with fund raising.
Merrie earned an AS degree from Santa Fe College, surgical tech certification from Manatee College and her Incubator Management Certification from INBIA.
Elliott works on programs and progress for startup companies and recently launched the Innovate NaviGator pilot program, which includes gathering and posting information for communitywide events for entrepreneurs.
Before joining UF Innovate, Elliott was a business development intern for ReliOx Corporation, a resident startup at Sid Martin Biotech; a legal assistant for Robert S. Griscti, Esq., assisting him in his practice of white-collar criminal law, criminal defense, federal and state litigation, professional licensing and appeals; and volunteered with the North Central Florida Chapter of the Federal Bar Association.
He earned his BA in history with a minor in teaching English as a second language (2013) and MBA focusing on entrepreneurship and marketing (2017) from UF. He was a Bob Graham Center for Public Service Student Fellow and Poe Center for Business Ethics Education and Research MBA Fellow.
Greg oversees the more than $2 million of common equipment at Sid Martin Biotech. As a scientist himself, he is responsible for providing training on and supervising the proper use of each piece of equipment, planning for new equipment purchases, and assisting in coordinating repairs. He also coordinates with UF EH&S on laboratory safety.
Greg has been an active member of the scientific community for over 20 years, both in academic and semi-industrial settings. He began his professional career as a laboratory technician investigating glucose transporter function. As a graduate student, he generated novel transgenic mouse models and contributed to the understanding of the adult neural and hematopoietic stem cell compartments. His post-doctoral research focused on the role of microglia in the brain as they pertain to neurogenesis, and he investigated therapies for acute myeloid leukemia as a research assistant scientist. He left academia in 2013 to join the biotechnology start-up community, working to develop novel and efficacious therapies for type 1 diabetes.
Greg is the Manager and Senior Scientist at OneVax, with a concurrent role on the Sid Martin Biotech staff. He holds a B.S. in Biology from Saint Andrews University in North Carolina, and a Ph.D. in Genetics from the University of Florida College of Medicine.